Creative Planning’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$772K Buy
86,197
+8,748
+11% +$78.4K ﹤0.01% 2064
2025
Q1
$581K Sell
77,449
-5,776
-7% -$43.3K ﹤0.01% 2148
2024
Q4
$626K Buy
83,225
+33,878
+69% +$255K ﹤0.01% 2022
2024
Q3
$375K Buy
49,347
+2,734
+6% +$20.8K ﹤0.01% 2341
2024
Q2
$288K Buy
46,613
+20,014
+75% +$124K ﹤0.01% 2374
2024
Q1
$135K Buy
26,599
+12,987
+95% +$66K ﹤0.01% 2645
2023
Q4
$81.5K Buy
+13,612
New +$81.5K ﹤0.01% 2581
2021
Q2
Sell
-18,459
Closed -$188K 2022
2021
Q1
$188K Buy
+18,459
New +$188K ﹤0.01% 2073
2018
Q2
Sell
-18,350
Closed -$88K 1917
2018
Q1
$88K Buy
+18,350
New +$88K ﹤0.01% 1749
2017
Q3
Sell
-17,800
Closed -$99K 2016
2017
Q2
$99K Buy
17,800
+15,615
+715% +$86.8K ﹤0.01% 1988
2017
Q1
$18K Sell
2,185
-23,765
-92% -$196K ﹤0.01% 3155
2016
Q4
$164K Buy
25,950
+1,550
+6% +$9.8K ﹤0.01% 1510
2016
Q3
$108K Buy
24,400
+8,000
+49% +$35.4K ﹤0.01% 1785
2016
Q2
$47K Buy
16,400
+3,900
+31% +$11.2K ﹤0.01% 2154
2016
Q1
$35K Buy
12,500
+1,100
+10% +$3.08K ﹤0.01% 2327
2015
Q4
$118K Buy
11,400
+4,100
+56% +$42.4K ﹤0.01% 1521
2015
Q3
$83K Buy
+7,300
New +$83K ﹤0.01% 1688
2015
Q2
Sell
-800
Closed -$7K 1227
2015
Q1
$7K Hold
800
﹤0.01% 3323
2014
Q4
$10K Sell
800
-305
-28% -$3.81K ﹤0.01% 3063
2014
Q3
$11K Buy
1,105
+300
+37% +$2.99K ﹤0.01% 2841
2014
Q2
$10K Hold
805
﹤0.01% 2799
2014
Q1
$9K Buy
805
+5
+0.6% +$56 ﹤0.01% 2743
2013
Q4
$6K Hold
800
﹤0.01% 2758
2013
Q3
$6K Hold
800
﹤0.01% 2651
2013
Q2
$1K Buy
+800
New +$1K ﹤0.01% 2925